Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
| 17 | 3 | IMMUNOLOGY//JOURNAL OF IMMUNOLOGY//IMMUNOL | 124793 |
| 335 | 2 | CTLA 4//PD L1//PD 1 | 18269 |
| 255 | 1 | PD L1//PD 1//IPILIMUMAB | 3851 |
| 1728 | 1 | INTERDISCIPLINARY PROGRAM IMMUNOL//CD8 T CELLS//JOURNAL OF IMMUNOLOGY | 2539 |
| 1947 | 1 | CD40//CD40 LIGAND//CD40L | 2453 |
| 4537 | 1 | CD80//CD28//B7 | 1797 |
| 8064 | 1 | 4 1BB//OX40//CD137 | 1319 |
| 8498 | 1 | IL 21//INTERLEUKIN 21//T FOLLICULAR HELPER CELLS | 1278 |
| 9976 | 1 | CTLA 4//CTLA 4 GENE//CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 | 1134 |
| 12204 | 1 | REGULATORY B CELLS//B10 CELLS//BREGS | 953 |
| 16009 | 1 | TIM 3//GALECTIN 9//TIM 1 | 705 |
| 17504 | 1 | CD30//SOLUBLE CD30//SCD30 | 623 |
| 21841 | 1 | ANERGY//RNF13//ANERGY INDUCTION | 427 |
| 22643 | 1 | B7 H4//B7 H3//SOLUBLE B7 H4 | 396 |
| 23593 | 1 | CD70//CD27//SOLUBLE CD27 | 364 |
| 24712 | 1 | ICOS//B7RP 1//INDUCIBLE COSTIMULATOR | 327 |
| 36129 | 1 | LAG 3//LYMPHOCYTE ACTIVATION GENE 3//CD223 | 103 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | CTLA 4 | authKW | 620797 | 3% | 59% | 615 |
| 2 | PD L1 | authKW | 601981 | 3% | 70% | 502 |
| 3 | PD 1 | authKW | 586279 | 3% | 63% | 537 |
| 4 | COSTIMULATION | authKW | 467581 | 3% | 43% | 626 |
| 5 | CD40 | authKW | 388019 | 3% | 45% | 503 |
| 6 | IPILIMUMAB | authKW | 349777 | 2% | 63% | 325 |
| 7 | NIVOLUMAB | authKW | 329112 | 1% | 73% | 263 |
| 8 | IMMUNOLOGY | WoSSC | 229022 | 53% | 1% | 9681 |
| 9 | PEMBROLIZUMAB | authKW | 218334 | 1% | 75% | 170 |
| 10 | TIM 3 | authKW | 213336 | 1% | 80% | 155 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Immunology | 229022 | 53% | 1% | 9681 |
| 2 | Oncology | 20449 | 19% | 0% | 3462 |
| 3 | Medicine, Research & Experimental | 10001 | 10% | 0% | 1796 |
| 4 | Hematology | 3836 | 5% | 0% | 947 |
| 5 | Cell Biology | 3029 | 9% | 0% | 1568 |
| 6 | Transplantation | 2492 | 3% | 0% | 512 |
| 7 | Rheumatology | 1202 | 2% | 0% | 326 |
| 8 | Allergy | 1140 | 1% | 0% | 250 |
| 9 | Pathology | 620 | 2% | 0% | 425 |
| 10 | Virology | 424 | 2% | 0% | 309 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | IMMUNOL | 143408 | 14% | 3% | 2645 |
| 2 | LUDWIG CANC IMMUNOTHER Y | 61857 | 0% | 56% | 64 |
| 3 | EMORY VACCINE | 53495 | 1% | 17% | 186 |
| 4 | INTERDISCIPLINARY PROGRAM IMMUNOL | 45390 | 1% | 26% | 101 |
| 5 | EARLE A CHILES | 44891 | 0% | 33% | 78 |
| 6 | IMMUNOL IMMUNOPATHOL | 44119 | 0% | 37% | 70 |
| 7 | IMMUNOMODULAT | 40855 | 0% | 31% | 76 |
| 8 | MOL IMMUNOL | 31464 | 2% | 6% | 328 |
| 9 | MICROBIOL IMMUNOL | 30569 | 6% | 2% | 1102 |
| 10 | ROBERT W FRANZ CANC | 27890 | 0% | 33% | 49 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | JOURNAL OF IMMUNOLOGY | 160504 | 12% | 4% | 2250 |
| 2 | EUROPEAN JOURNAL OF IMMUNOLOGY | 55865 | 4% | 5% | 660 |
| 3 | CANCER IMMUNOLOGY RESEARCH | 52709 | 1% | 25% | 125 |
| 4 | IMMUNITY | 43029 | 2% | 8% | 298 |
| 5 | ONCOIMMUNOLOGY | 32934 | 1% | 13% | 150 |
| 6 | JOURNAL OF EXPERIMENTAL MEDICINE | 30531 | 3% | 4% | 474 |
| 7 | NATURE IMMUNOLOGY | 20308 | 1% | 7% | 165 |
| 8 | INTERNATIONAL IMMUNOLOGY | 18832 | 1% | 5% | 212 |
| 9 | JOURNAL OF IMMUNOTHERAPY | 13618 | 1% | 7% | 117 |
| 10 | CURRENT OPINION IN IMMUNOLOGY | 12181 | 1% | 5% | 142 |
Author Key Words |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | CTLA 4 | 620797 | 3% | 59% | 615 | Search CTLA+4 | Search CTLA+4 |
| 2 | PD L1 | 601981 | 3% | 70% | 502 | Search PD+L1 | Search PD+L1 |
| 3 | PD 1 | 586279 | 3% | 63% | 537 | Search PD+1 | Search PD+1 |
| 4 | COSTIMULATION | 467581 | 3% | 43% | 626 | Search COSTIMULATION | Search COSTIMULATION |
| 5 | CD40 | 388019 | 3% | 45% | 503 | Search CD40 | Search CD40 |
| 6 | IPILIMUMAB | 349777 | 2% | 63% | 325 | Search IPILIMUMAB | Search IPILIMUMAB |
| 7 | NIVOLUMAB | 329112 | 1% | 73% | 263 | Search NIVOLUMAB | Search NIVOLUMAB |
| 8 | PEMBROLIZUMAB | 218334 | 1% | 75% | 170 | Search PEMBROLIZUMAB | Search PEMBROLIZUMAB |
| 9 | TIM 3 | 213336 | 1% | 80% | 155 | Search TIM+3 | Search TIM+3 |
| 10 | CD40 LIGAND | 208671 | 1% | 52% | 232 | Search CD40+LIGAND | Search CD40+LIGAND |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 2 |